As Congress debates whether to extend the temporary federal subsidies that have helped millions of Americans buy health coverage, a crucial underlying reality is sometimes overlooked: Those subsidies are merely a band-aid covering the often unaffordable cost of health care. California, Massachusetts, Connecticut, and five other states have set caps on health care spending in…
As the field of oncology evolves, we need to shift away from traditional binary “yes-no” biomarkers to a more nuanced, spatial understanding of tumor biology. This approach will allow for more personalized treatment plans that are tailored to the unique characteristics of each patient’s tumor. The post Targeting the Blast Radius: Why Spatial AI Diagnostics…
PureTech Health spinout Celea Therapeutics will apply the financing toward a Phase 3 test of its idiopathic pulmonary (IPF) drug, deupirfenidone. The pivotal study will test the oral small molecule head-to-head against a standard of care IPF drug. The post Lung-Focused Celea Secures $180M for Pivotal Test of Pulmonary Fibrosis Drug appeared first on MedCity…
Matt Anderson, M.D., M.B.A., responds to a Qventus survey of more than 60 CIOs, Chief AI Officers, and CMIOs
The gap between how nicotine use has evolved and how cessation treatment has evolved is a meaningful part of why quit rates have plateaued. The post Smoking Cessation’s Quiet Design Failure appeared first on MedCity News.
In her house in Ypsilanti, Michigan, Barbara Meade said, “there are walkers and wheelchairs and oxygen and cannulas all over the place.” Barbara, 82, has chronic obstructive pulmonary disease, so a portable oxygen tank accompanies her everywhere. Spinal stenosis limits her mobility, necessitating the walkers and wheelchairs and considerable help from her husband, Dennis, who…
Abortion has emerged as the most important issue in the November election for women under 30, according to a survey by KFF — a notable change since late spring, before Vice President Kamala Harris entered the presidential race. Nearly 4 in 10 women under 30 surveyed in September and early October told pollsters that abortion…
Scribe Therapeutics’ IPO will support a pipeline led by a genetic medicine that represses expression of its target gene without making permanent changes. Common chronic cardiometabolic conditions are Scribe’s initial focus as the biotech works to bring genetic medicines beyond rare diseases. The post CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO…
The FDA approved Moderna’s flu vaccine mFLUSIVA, a regulatory decision that comes six months after the agency refused to review the mRNA shot and then quickly reversed its position. But a recommendation from a Centers for Disease Control and Prevention advisory committee is key for payer coverage, and that committee has not met all year…
We now have technology that can address the problems faced by so many rural hospitals, improving both patient outcomes and an organization’s bottom line. The post It Doesn’t All Have to Be Doom and Gloom for Rural Hospitals – A Blueprint for Improving Cost Structures appeared first on MedCity News.